Article
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Genome biology - 13 Mar 2023
Goldswain Hannah, Dong Xiaofeng, Penrice-Randal Rebekah, Alruwaili Muhannad, Shawli Ghada T, Prince Tessa, Williamson Maia Kavanagh, Raghwani Jayna, Randle Nadine, Jones Benjamin, Donovan-Banfield I'ah, Salguero Francisco J, Tree Julia A, Hall Yper, Hartley Catherine, Erdmann Maximilian, Bazire James, Jearanaiwitayakul Tuksin, Semple Malcolm G, Openshaw Peter J M, Baillie J Kenneth, Emmett Stevan R, Digard Paul, Matthews David A, Turtle Lance, Darby Alistair C, Davidson Andrew D, Carroll Miles W, Hiscox Julian A
Abstract excerpt
BACKGROUND: The mutational landscape of SARS-CoV-2 varies at the dominant viral genome sequence and minor genomic variant population. During the COVID-19 pandemic, an early substitution in the genome was the D614G change in the spike protein, associated with an increase in transmissibility. Genomes with D614G are accompanied by a P323L substitution in the viral polymerase (NSP12). However, P323L is not thought to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
